GlobeNewswire
BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for IGALMI® Label Expansion in the At-Home Setting
📈
AI Sentiment
Highly Positive
8/10
BioXcel Therapeutics Inc. News
Latest updates and market news for BTAI
2 news
Jan 16 - Jan 22, 2026
Page 1
Share this news page